ADRIAN BUNTA: Open Payments
NPI 1043542061 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,646 in 135 payments from 24 companies in 2025. Trend: 2023 $15,600 · 2024 $19,404 · 2025 $17,646
Speaker / faculty: $13,150Food & beverage: $2,789Travel & lodging: $1,194Consulting: $330Education: $183
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $12,965 |
| Otsuka America Pharmaceutical, Inc. | 9 | $2,742 |
| UCB, Inc. | 18 | $362 |
| ABBVIE INC. | 16 | $229 |
| PFIZER INC. | 8 | $145 |
| Eisai Inc. | 7 | $137 |
| Genentech USA, Inc. | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Biogen, Inc. | 5 | $96 |
| Lundbeck LLC | 5 | $91 |
Products named: AUSTEDO XR, REXULTI, Briviact, UZEDY, Leqembi, AJOVY, QULIPTA, KESIMPTA.
Industry payments across AZ — which companies pay providers there.
